279
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Lipid-core nanocapsules are an alternative to the pulmonary delivery and to increase the stability of statins

, , , , , , , , ORCID Icon, ORCID Icon, & show all
Pages 317-326 | Received 23 Dec 2018, Accepted 23 May 2019, Published online: 19 Jun 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Azlan Kamari, Siti Najiah Mohd Yusoff, Siew Tin Susana Wong, Esther Phillip, Justin S. J. Hargreaves & Hidayatulfathi Othman. (2023) Betel essential oil-loaded lipid-core nanocapsules as mosquito repellent spray formulations for fabric finishes. The Journal of The Textile Institute 114:1, pages 10-21.
Read now

Articles from other publishers (8)

Dan-Li Hao, Ya-Jie Wang, Jia-Ying Yang, Ran Xie, Ling-Yu Jia, Jin-Tang Cheng, Hai Ma, Ji-Xiang Tian, Shan-Shan Guo, Ting Liu, Feng Sui, Yu Zhao, Yan-Jun Chen & Qing-He Zhao. (2022) The Alleviation of LPS-Induced Murine Acute Lung Injury by GSH-Mediated PEGylated Artesunate Prodrugs. Frontiers in Pharmacology 13.
Crossref
Manish Kumar, Abhishek Jha, Kanchan Bharti, Gourav Parmar & Brahmeshwar Mishra. (2022) Advances in lipid-based pulmonary nanomedicine for the management of inflammatory lung disorders. Nanomedicine 17:12, pages 913-934.
Crossref
Lali Ronsoni Zancan, Franciele Aline Bruinsmann, Karine Paese, Patrick Türck, Alan Bahr, Alexsandra Zimmer, Cristina Campos Carraro, Paulo Cavalheiro Schenkel, Adriane Belló-Klein, Claiton I. Schwertz, David Driemeier, Adriana Raffin Pohlmann & Sílvia Stanisçuaski Guterres. (2021) Oral delivery of ambrisentan-loaded lipid-core nanocapsules as a novel approach for the treatment of pulmonary arterial hypertension. International Journal of Pharmaceutics 610, pages 121181.
Crossref
Sheersha Pramanik, Sourav Mohanto, Ravi Manne, Rahul R. Rajendran, A. Deepak, Sijo Joy Edapully, Triveni Patil & Oly Katari. (2021) Nanoparticle-Based Drug Delivery System: The Magic Bullet for the Treatment of Chronic Pulmonary Diseases. Molecular Pharmaceutics 18:10, pages 3671-3718.
Crossref
Ricardo Lorenzoni, Renata Vidor Contri, Cleverton Kleiton Freitas de Lima, Fabiano Barreto, Bibiana Verlindo de Araujo, Adriana Raffin Pohlmann, Ana Luísa Palhares de Miranda, Teresa Dalla Costa & Silvia Stanisçuaski Guterres. (2021) Dermatopharmacokinetic and pharmacodynamic evaluation of a novel nanostructured formulation containing capsaicinoids for treating neuropathic pain. International Journal of Pharmaceutics 596, pages 120294.
Crossref
Michele Pereira Moreira, Renata Gancine Budel, Julien Wergutz, Marina Lopes Machado, Bruna Costabeber Guerino, Félix Alexandre Antunes Soares, Luciana Maria Fontanari Krause, Aline Ferreira Ourique & Carina Rodrigues Boeck. (2020) Simvastatin-loaded nanoemulsions: development, characterization, stability study and toxicity assays. Therapeutic Delivery 11:8, pages 497-505.
Crossref
Ricardo Lorenzoni, Samuel Davies, Leticia Malgarim Cordenonsi, José Alcides da Silva Viçosa, Nathana Jamille Mezzomo, Amanda Lima de Oliveira, Guilherme Machado do Carmo, Renata Platcheck Raffin, Oswaldo Luiz Alves, Rodrigo De Almeida Vaucher & Virginia Cielo Rech. (2020) Lipid-core nanocapsules containing simvastatin improve the cognitive impairment induced by obesity and hypercholesterolemia in adult rats. European Journal of Pharmaceutical Sciences 151, pages 105397.
Crossref
Sean D. McCarthy, Héctor E. González & Brendan D. Higgins. (2020) Future Trends in Nebulized Therapies for Pulmonary Disease. Journal of Personalized Medicine 10:2, pages 37.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.